Clinical Trial Update: Serologically Active, Clinically Stable Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 clinical trial evaluating treatment for serologically active, clinically stable systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: NYU Langone Health | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED